![](/https/www.gene.com/assets/content/feature_asset_image/quita-quote-headshot_most_recent.jpg)
I believe inclusive research is research—full stop. One day we won’t need the qualifier inclusive because all clinical studies will represent the diversity of the patients we serve.
Always Design with Patient Equity in Mind
Clinical studies offer people with serious and life-threatening diseases a chance to receive investigational medicines that can potentially improve outcomes. At Genentech, we are deeply committed to addressing barriers to clinical study participation and advancing inclusive research.
Learn more about how Genentech seeks to create more equitable health outcomes through inclusive research.
More must be done to ensure clinical trial participants are representative of the entire patient population.
The U.S. Advancing Inclusive Research Site Alliance is a coalition of clinical research sites in oncology and ophthalmology that partner with Genentech to advance the representation of diverse patient populations in our clinical trials, test recruitment and retention approaches, and establish best practices that can be leveraged across the industry to help achieve health equity. Meet our site alliance champions.
I believe inclusive research is research—full stop. One day we won’t need the qualifier inclusive because all clinical studies will represent the diversity of the patients we serve.
We believe that advancing health equity is an ongoing process of addressing barriers that people face when accessing healthcare.
Information and support about Genentech sponsored trials.
Phone: (888) 662-6728
Monday-Friday, 5am-5pm PT
Provides free medicine to people without insurance coverage or who can’t pay for their Genentech medicines.
REFERENCES
1 Nabhan C, Choueiri TK, Mato AR. Rethinking Clinical Trials Reform During the COVID-19 Pandemic. JAMA Oncol. 2020;6(9):1327-1329. doi:10.1001/jamaoncol.2020.3142; for non-Caucasian participation (Hispanic and Latino): Coakley M, Fadiran EO, Parrish LJ, Griffith RA, Weiss E, Carter C. Dialogues on diversifying clinical trials: successful strategies for engaging women and minorities in clinical trials . J Womens Health (Larchmt). Jul 2012;21(7):713-6. doi:10.1089/jwh.2012.3733
2 Colby SL, Ortman JM. Rethinking Projections of the Size and Composition of the U.S. Population: 2014 to 2060.
3 Genomic Data Source: Rethinking Total GWAS Participants Diversity. GWAS Diversity Monitor.